Overcoming market access hurdles will be a challenge for Auvelity’s sponsor, Axsome Therapeutics. But, a favorable efficacy and safety profile will likely help to facilitate patient access.
Subscribe to:
Post Comments (Atom)
< + > Real-Time Pharma Insights: Philip Poulidis on Scaling ODAIA AI – Life Sciences Today Podcast Episode 41
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Philip Poulidis, ...
No comments:
Post a Comment